The article examines the misconception that large contract research organizations (CROs) offer the best talent for clinical trials simply because of their extensive resources. It highlights that while large CROs have vast networks, the prioritization of process over patient care can lead to slower, less effective results, and that specialized talent may not always be assigned to each project. This underscores the importance of evaluating whether a CRO’s approach truly aligns with your trial’s needs.
